Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

RIGL - RIGEL PHARMACEUTICALS INC

19.91
-0.520   -2.612%

Share volume: 146,445
Last Updated: 03-13-2025
Pharmaceutical Products/Pharmaceutical Preparations: 0.01%

PREVIOUS CLOSE
CHG
CHG%
$20.43
-0.52
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2023 06-30-2023 09-30-2023 12-31-2023 03-31-2024 06-30-2024 09-30-2024 12-31-2024
Fiscal Quarter Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Report Date 05-02-2023 08-01-2023 11-07-2023 03-05-2024 05-07-2024 08-06-2024 11-07-2024 03-04-2025
Total revenue 26.070 M 26.886 M 28.134 M 35.792 M 29.534 M 36.841 M 55.307 M 57.596 M
Cost of revenue 977.000 K 1.075 M 1.268 M 3.790 M 2.025 M 2.807 M 8.026 M 5.789 M
Gross profit 25.093 M 25.811 M 26.866 M 32.002 M 27.509 M 34.034 M 47.281 M 51.807 M
    2.86% 4.09% 19.12% -14.04% 23.72% 38.92% 9.57%  
Operating expenses 37.818 M 31.078 M 31.331 M 30.036 M 34.475 M 33.587 M 33.225 M 35.152 M
Selling general and admin 27.729 M 26.306 M 24.856 M 26.850 M 28.449 M 28.047 M 27.043 M 29.520 M
Research and development 10.089 M 4.772 M 6.475 M 3.186 M 6.026 M 5.540 M 6.182 M 5.632 M
Total expenses 38.795 M 32.153 M 32.599 M 33.826 M 36.500 M 33.587 M 33.225 M 35.152 M
    -17.12% 1.39% 3.76% 7.91% -7.98% -1.08% 5.80%  
Operating income -12.725 M -5.267 M -4.465 M 1.966 M -6.966 M 447.000 K 14.056 M 16.655 M
Ebit -12.725 M -5.267 M -4.465 M 1.966 M -6.966 M 447.000 K 14.056 M 16.655 M
Pretax income -13.536 M -6.600 M -5.692 M 737.000 K -8.247 M -1.030 M 12.421 M 15.222 M
    -51.24% -13.76% -112.95% -1,219.00% -87.51% -1,305.92% 22.55%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic -13.536 M -6.600 M -5.692 M 737.000 K -8.247 M 0.000 0.000 0.000
    51.24% 13.76% 112.95% -1,219.00% 100.00%      
Net income -13.536 M -6.600 M -5.692 M 737.000 K -8.247 M -1.030 M 12.421 M 14.341 M
    51.24% 13.76% 112.95% -1,219.00% 87.51% 1,305.92% 15.46%